Your browser doesn't support javascript.
loading
Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
Liu, Qi; Dong, Huijie; Li, Yuzhu; Shen, Yingying; Hong, Yilei; Chen, Ying; Liu, Shan; Wu, Xiaolian; Liu, Wenbin; Hu, Huijin; Zhao, Yuechao; Lin, Shenyun; Shen, Yiping; Zhou, Yuhong; Ye, Baodong; Wu, Dijiong.
Affiliation
  • Liu Q; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Dong H; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Li Y; Department of Respiratory Medicine, Haining Traditional Chinese Medical Hospital of Zhejiang Province, Haining, Zhejiang, China.
  • Shen Y; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Hong Y; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Chen Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005), Zhejiang, People's Republic of China.
  • Liu S; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Wu X; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Liu W; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005), Zhejiang, People's Republic of China.
  • Hu H; Department of Clinical Evaluation Center, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Zhao Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005), Zhejiang, People's Republic of China.
  • Lin S; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Shen Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005), Zhejiang, People's Republic of China.
  • Zhou Y; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Ye B; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005), Zhejiang, People's Republic of China.
  • Wu D; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Lipids Health Dis ; 21(1): 93, 2022 Oct 04.
Article de En | MEDLINE | ID: mdl-36192750
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Anémie aplasique Type d'étude: Observational_studies / Prognostic_studies Limites: Humans / Middle aged Langue: En Journal: Lipids Health Dis Sujet du journal: BIOQUIMICA / METABOLISMO Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Anémie aplasique Type d'étude: Observational_studies / Prognostic_studies Limites: Humans / Middle aged Langue: En Journal: Lipids Health Dis Sujet du journal: BIOQUIMICA / METABOLISMO Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni